Sotorasib Dosing Regimen - EP4593837

The patent EP4593837 was granted to Amgen on Aug 6, 2025. The application was originally filed on Dec 16, 2022. The patent is currently recorded with a legal status of "Pending".

EP4593837

AMGEN
Filing Date
Dec 16, 2022
Status
Pending
Grant Date
Aug 6, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Get instant alerts for new documents